Mbwa Aina ya Upungufu wa Kushikamana kwa Leukocyte ya Canine Iii (CLAD3)

Canine Leukocyte Adhesion Deficiency Type III (CLAD3) is a rare genetic disorder affecting a dog’s immune system, leading to severe infections and poor wound healing. A DNA test for CLAD3 helps identify carriers and affected dogs, enabling responsible breeding decisions to prevent the spread of this condition. Early detection through genetic testing is crucial for managing the health of at-risk breeds. By using a reliable CLAD3 DNA test, breeders and veterinarians can improve canine health outcomes and reduce the incidence of this immune deficiency. Protect your dog’s future with accurate genetic screening for CLAD3 today. Stay informed and ensure your dog’s well-being with advanced DNA testing options.

Ufupisho: CLAD3

Mabadiliko yaliyochanganuliwa: FERMT3 c.1349_1350insAAGACGGCTGCC

Urithi: Autosomal Recessive

Kifupi

CLAD3

Marudio yaliyozingatiwa

Nadra

Ukali wa kliniki

Mkali

Uainishaji wa kliniki

Magonjwa ya Immunological

Mabadiliko yaliyochanganuliwa

FERMT3 c.1349_1350insAAGACGGCTGCC
p.(L450_A451insRRLP)

Njia ya urithi

Autosomal Recessive (Kamili)

Muhtasari wa jaribio:

Canine Leukocyte Adhesion Deficiency Type III (CLAD3) is a rare genetic disorder affecting a dog’s immune system. It impairs the ability of white blood cells to adhere and migrate to infection sites, leading to severe and recurrent infections. A DNA test can identify carriers and affected dogs by detecting mutations responsible for CLAD3. Early diagnosis through testing helps breeders make informed decisions to reduce the spread of this condition. Managing affected dogs requires veterinary care to address infections and support immune function.

Inapatikana kutoka kwa kifurushi: Basic

Jaribio hili la DNA limejumuishwa kuanzia kwenye pakiti yetu Basic - na pia ni sehemu ya vifurushi Basic, Standard, Advanced, Complete.

Tazama Vifurushi vya Uchunguzi wa DNA →

Chagua kifurushi kinacholingana vyema na ufugaji wako au mkakati wa afya wa wanyama wako.

Understanding Canine Leukocyte Adhesion Deficiency Type III (CLAD3)

Canine Leukocyte Adhesion Deficiency Type III (CLAD3) is a genetic disorder that affects the immune system of dogs. This condition is characterized by a defect in the leukocyte adhesion process, which is critical for the proper functioning of the immune system. The deficiency disrupts the ability of white blood cells, or leukocytes, to adhere to blood vessel walls, preventing them from migrating to sites of infection or inflammation. As a result, affected dogs are more susceptible to infections and may experience chronic health issues.

Clinical Symptoms of CLAD3

Dogs with CLAD3 typically exhibit a range of clinical symptoms that are indicative of a compromised immune system. Common signs include recurrent infections, poor wound healing, and an increased frequency of inflammatory conditions. Affected dogs may also present with symptoms such as lethargy, fever, and swelling due to the inability of immune cells to effectively respond to pathogens.

Pathophysiology of CLAD3

The underlying cause of CLAD3 lies in a mutation within specific genes responsible for the production of adhesion molecules on leukocytes. These molecules are essential for the leukocyte's ability to stick to and traverse the endothelial cells lining blood vessels. When this adhesion process is impaired, the immune response is significantly weakened, leading to the clinical manifestations associated with the condition. This genetic mutation can lead to lifelong health challenges for affected dogs.

Diagnosis of CLAD3

Diagnosis of Canine Leukocyte Adhesion Deficiency Type III involves genetic testing to identify the specific mutation responsible for the condition. A DNA test can confirm the presence of the mutation, allowing for an accurate diagnosis. This diagnostic tool is particularly valuable for breeders and veterinarians, as it helps identify at-risk individuals and informs breeding decisions to reduce the prevalence of the disorder within certain populations.

Management and Treatment Options

While there is currently no cure for CLAD3, management of affected dogs focuses on supporting their immune system and minimizing the risk of infections. This may include regular veterinary check-ups, prompt treatment of infections, and maintaining a clean environment to reduce exposure to pathogens. Additionally, owners may need to monitor their dogs closely for any signs of illness and seek veterinary care as needed.

Hitimisho

Canine Leukocyte Adhesion Deficiency Type III is a serious genetic disorder that poses significant challenges for affected dogs due to their compromised immune function. Understanding the condition, recognizing its symptoms, and pursuing genetic testing are crucial steps in managing the health of dogs at risk. By raising awareness and educating dog owners and breeders, it is possible to mitigate the impact of this condition on canine health.

Uzazi unaotambuliwa kwa mtihani: Aina ya Upungufu wa Kushikamana kwa Leukocyte ya Canine Iii (CLAD3)

American White Shepherd Dog
German Shepherd Dog
Shiloh Shepherd
Swiss White Shepherd Dog

Ufafanuzi wa genotypes Genotype Hali Jifunze zaidi kuhusu tafsiri ya genotypes Maswali Yanayoulizwa Mara kwa Mara: kuelewa tafsiri ya matokeo "Futa" inamaanisha nini? Mnyama hana kubeba mabadiliko. Haitaendeleza ugonjwa huo na haitapita. Je, "Mbebaji" ni mbaya? Hapana. Kwa ujumla mnyama huyo ana afya nzuri lakini anaweza kupitisha mabadiliko hayo kwa watoto wake. Je, ikiwa mnyama "Ameathirika"? Inabeba nakala mbili zilizobadilishwa. Ishara za kliniki zinatarajiwa kulingana na ugonjwa huo. Haipaswi kufugwa. Kwa nini kuna tofauti kati ya wanaume na wanawake? Magonjwa mengine yanahusishwa na ngono, kwa hivyo usemi wao hutofautiana kulingana na jinsia ya mnyama. Mnyama ana nakala mbili za kawaida za jeni. Hakuna hatari ya kuendeleza au kusambaza ugonjwa huo. Mtoa huduma wa Heterozygous: nakala moja iliyobadilishwa. Mnyama kwa kawaida haathiriwi kiafya lakini anaweza kupitisha mabadiliko kwa watoto. Mbebaji wa kiume au walioathirika kulingana na hali ya urithi. Wanaume wana kromosomu moja tu ya X au Y. Mbebaji wa kike wa Heterozygous: nakala moja iliyobadilishwa. Anaweza kupitisha mabadiliko na wakati mwingine anaweza kuonyesha dalili za kliniki kidogo kulingana na hali. Nakala mbili zilizobadilishwa za jeni. Mnyama yuko katika hatari ya kuendeleza hali inayohusiana.

🧬 Interpretation of genotypes CLAD3

Genotype

Hali

🟡 N/N

Isiyo ya mtoa huduma - Hakuna Hatari

🟡 N/CLAD3

Mtoa huduma - Hakuna Hatari

❌ CLAD3/CLAD3

Walioathirika - Katika Hatari

Maswali Yanayoulizwa Mara kwa Mara: kuelewa tafsiri

"Futa" inamaanisha nini?

Mnyama hana kubeba mabadiliko. Haitaendeleza ugonjwa huo na hataipitisha.

Je, "Mbebaji" ni mbaya?

Hapana. Kwa ujumla mnyama huyo ana afya nzuri lakini anaweza kupitisha mabadiliko hayo uzao.

Je, ikiwa mnyama "Ameathirika"?

Inabeba nakala mbili zilizobadilishwa. Ishara za kliniki zinatarajiwa kulingana na ugonjwa huo. Haipaswi kufugwa.

Kwa nini kuna tofauti kati ya wanaume na wanawake?

Baadhi ya magonjwa yanahusishwa na ngono, hivyo kujieleza kwao hutofautiana kulingana na ngono ya mnyama.

Utabiri wa Genotype kwa Watoto Mama Baba isiyo-ya-mtoa-huduma Mtoa huduma Imeathiriwa Msalaba unaopendeza: wengi Hatari ya mtoa huduma inaongoza. Wengi walioathirika Chuja kwa genotype ya mama Chuja kulingana na aina ya baba Wote Bashiri Uzao Mnyama ana nakala mbili za kawaida za jeni. Hakuna hatari ya kuendeleza au kusambaza ugonjwa huo. Mtoa huduma wa Heterozygous: nakala moja iliyobadilishwa. Mnyama kwa kawaida haathiriwi kiafya lakini anaweza kupitisha mabadiliko kwa watoto. Mbebaji wa kiume au walioathirika kulingana na hali ya urithi. Wanaume wana kromosomu moja tu ya X au Y. Mbebaji wa kike wa Heterozygous: nakala moja iliyobadilishwa. Anaweza kupitisha mabadiliko na wakati mwingine anaweza kuonyesha dalili za kliniki kidogo kulingana na hali. Nakala mbili zilizobadilishwa za jeni. Mnyama yuko katika hatari ya kuendeleza hali inayohusiana.

Bashiri Uzao

Chuja kwa genotype ya mama Chuja kulingana na aina ya baba

N/N (isiyo-ya-mtoa-huduma)

N/CLAD3 (Mtoa huduma)

CLAD3/CLAD3 (Imeathiriwa)

Maswali Yanayoulizwa Mara kwa Mara ya Uchunguzi wa DNA

Je, kipimo hiki cha DNA kinagundua nini?

This DNA test detects the mutation associated with Canine Leukocyte Adhesion Deficiency Type Iii (CLAD3) in order to identify clear, carrier, or at-risk animals.

Kwa nini ujaribu mnyama anayezaa?

Upimaji wa DNA huwasaidia wafugaji kupanga uzazi salama na kupunguza hatari ya kusambaza mabadiliko hayo kwa watoto.

Njia ya urithi wa jaribio hili ni nini?

Hali ya urithi iliyoripotiwa kwa jaribio hili ni Autosomal Recessive.

Ni mabadiliko gani yanachanganuliwa katika jaribio hili?

This test analyses the mutation FERMT3 c.1349_1350insAAGACGGCTGCC.

Je, ni lazima mnyama wa kubeba anaathirika?

Si lazima. Ufafanuzi unategemea muundo wa urithi na genotype inayotokana.

Marejeleo

Boudreaux M K, Wardrop K J, Kiklevich V, Felsburg P, Snekvik K. A mutation in the canine Kindlin-3 gene associated with increased bleeding risk and susceptibility to infections. Thromb Haemost. 2010 Feb;103(2):475-7. doi: 10.1160/TH09-09-0571. Epub 2009 Nov 13.

DNA Portal yangu